Clinical trial
Open access
Sep 2026
A pilot phase IIa randomized, placebo-controlled, double-blind trial of intravenous human pluripotent adipose-derived stem cells (PASCs) in Parkinson's disease: The REPOSE study.
Repeated intravenous PASC administration is safe and feasible in PD, and the exploratory findings are hypothesis-generating, supporting further investigation in adequately powered Phase IIb/III trials.
María Laura Gimeno, G. Chazenbalk, Lisa Riggioni et al.
· Cell Transplantation · 0 citations